Balance Sheet
Cash Flow Statement
Amortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Amn Healthcare Services (AMN) over the last 16 years, with FY2024 value amounting to -$259.4 million.

  • Amn Healthcare Services' Cash from Financing Activities fell 1776.94% to -$71.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$273.9 million, marking a year-over-year decrease of 2532.41%. This contributed to the annual value of -$259.4 million for FY2024, which is 251819.37% down from last year.
  • Amn Healthcare Services' Cash from Financing Activities amounted to -$259.4 million in FY2024, which was down 251819.37% from $10.7 million recorded in FY2023.
  • Over the past 5 years, Amn Healthcare Services' Cash from Financing Activities peaked at $211.5 million during FY2020, and registered a low of -$591.9 million during FY2022.
  • Its 5-year average for Cash from Financing Activities is -$132.8 million, with a median of -$34.9 million in 2021.
  • In the last 5 years, Amn Healthcare Services' Cash from Financing Activities skyrocketed by 10181.27% in 2023 and then plummeted by 251819.37% in 2024.
  • Amn Healthcare Services' Cash from Financing Activities (Annual) stood at $211.5 million in 2020, then tumbled by 116.5% to -$34.9 million in 2021, then tumbled by 1596.13% to -$591.9 million in 2022, then surged by 101.81% to $10.7 million in 2023, then crashed by 2518.19% to -$259.4 million in 2024.
  • Its Cash from Financing Activities stands at -$259.4 million for FY2024, versus $10.7 million for FY2023 and -$591.9 million for FY2022.